Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19

INTRODUCTION: the current worldwide outbreak of Coronavirus disease 2019 (COVID-19) due to a novel coronavirus (SARS-CoV-2) is seriously threatening the public health. The number of infected patients is continuously increasing and the need for Intensive Care Unit admission ranges from 5 to 26%. The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Lei, Chong, Su, Binxiao, Dong, Hailong, Fakhr, Bijan Safaee, Grassi, Luigi Giuseppe, Di Fenza, Raffaele, Gianni, Stefano, Pinciroli, Riccardo, Vassena, Emanuele, Morais, Caio Cesar Araujo, Bellavia, Andrea, Spina, Stefano, Kacmarek, Robert, Berra, Lorenzo
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239076/
https://ncbi.nlm.nih.gov/pubmed/32511450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.03.10.20033522
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars